2016
DOI: 10.1007/s40618-016-0535-4
|View full text |Cite
|
Sign up to set email alerts
|

Influence of short-term selenium supplementation on the natural course of Hashimoto’s thyroiditis: clinical results of a blinded placebo-controlled randomized prospective trial

Abstract: The short-term L-selenomethionine supplementation has a limited impact on the natural course in euthyroid HT. Our results tip the balance toward the ineffectiveness of short-term L-selenomethionine supplementation in HT.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
44
0
5

Year Published

2017
2017
2019
2019

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(61 citation statements)
references
References 32 publications
2
44
0
5
Order By: Relevance
“…A paper (31) evaluated the real efficacy of selenium supplementation in HT, measuring thyroid-stimulating hormone (TSH), thyroid hormones, TPOAb and thyroglobulin antibodies (TgAb) levels, and thyroid echogenicity after 6 months of l -selenomethionine treatment. The authors concluded that the short-term l -selenomethionine supplementation has a restricted impact on the natural course in euthyroid HT.…”
Section: Environmental Factorsmentioning
confidence: 99%
“…A paper (31) evaluated the real efficacy of selenium supplementation in HT, measuring thyroid-stimulating hormone (TSH), thyroid hormones, TPOAb and thyroglobulin antibodies (TgAb) levels, and thyroid echogenicity after 6 months of l -selenomethionine treatment. The authors concluded that the short-term l -selenomethionine supplementation has a restricted impact on the natural course in euthyroid HT.…”
Section: Environmental Factorsmentioning
confidence: 99%
“…Selenium is an essential micronutrient modulating several physiopathological processes in the thyroid gland [59]. Its anticancer role has been recently demonstrated [60], as well as the ability to act as antiapoptotic factor in thyroid follicular cells [61].…”
Section: Volcanic Areamentioning
confidence: 99%
“…There is no question that the use of selenium in autoimmune thyroiditis, as a measure to prevent the development of hypothyroidism [3] or to provide a benefit in patients already receiving levothyroxine, is not supported by unequivocal evidence. In this regard, prospective, possibly randomized, studies are needed, and we agree that selenium should not be given to patients with autoimmune thyroiditis until evidence for a beneficial effect is convincingly provided.…”
mentioning
confidence: 99%